Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30267037.
- Also identified by DOI 10.1001/jamaoncol.2018.4300 and PMC identifier 6584270.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses the European Society of Medical Oncology Magnitude of Clinical Benefit Scale to evaluate the clinical benefit of anticancer drugs that gained approval by the US Food and Drug Administration based on single-arm rather than randomized clinical trials.
Medical subject headings
- Antineoplastic Agents
- Drug Approval